B. Riley Wealth Management’s Anixa Biosciences ANIX Stock Holding History

B. Riley Wealth Management’s Portfolio ANIX Stock Details ANIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$50	Hold	16,200	–	–	﹤0.01%	728
2022 Q1	$44K	Sell	16,200 -800	-5%	-$2.35K	﹤0.01%	612
2021 Q4	$50K	Buy	17,000 +5,000	+42%	+$20.2K	﹤0.01%	642
2021 Q3	$57K	Hold	12,000	–	–	﹤0.01%	624
2021 Q2	$47K	Hold	12,000	–	–	0.01%	419
2021 Q1	$56K	Hold	12,000	–	–	0.01%	420
2020 Q4	$37K	Buy	+12,000	New	+$30.2K	﹤0.01%	377

Other funds holding ANIX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

LFCM

Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

B. Riley Wealth Management's ANIX Position: Q2 2022 in Review

B. Riley Wealth Management held its Anixa Biosciences (ANIX) position steady in Q2 2022 at 16,200 shares worth $50. The position accounts for ﹤0.01% of the portfolio, ranked #728.

B. Riley Wealth Management first reported a position in ANIX in Q4 2020 and has held it in 7 quarters since. The position peaked at $57K in Q3 2021. 45 funds tracked by Wall St. Rank hold ANIX as of Q2 2022.

B. Riley Wealth Management held 16,200 shares of Anixa Biosciences worth $50 as of Q2 2022.
B. Riley Wealth Management left its Anixa Biosciences share count unchanged in Q2 2022.
Anixa Biosciences made up ﹤0.01% of B. Riley Wealth Management's portfolio in Q2 2022, its #728 holding.
B. Riley Wealth Management first reported a position in Anixa Biosciences in Q4 2020 and has held it in 7 quarters since.
B. Riley Wealth Management's Anixa Biosciences position peaked at $57K in Q3 2021.
45 funds tracked by Wall St. Rank held Anixa Biosciences as of Q2 2022.

Based on B. Riley Wealth Management's 13F filing for Q2 2022, filed 9 Sep 2022.